Court Schedule
d. Court Documents
g. RNAi Reviews
Links
- Alnylam Pharmaceuticals
- Christopher M. Morrison, Lead Attorney for Whitehead
- David Bartel & Lab
- David I. Gindler, Max-Planck Lead Attorney
- Debra G. Josephson - Lead attorney for Utah
- Dirk Haussecker’s RNAi Blog
- Donald R. Ware, Lead Attorney for UMass
- Dr. Tuschl’s Faculty webpage
- Glenn Pfadenhauer, Lead Attorney for Whitehead
- Judge Saris
- Michael Strub, Lead Attorney for Max-Planck
- Morgan Chu, Lead Attorney for Max-Planck
- Nicholas S. Boebel - Attorney for Utah
- Phillip Sharp & Lab
- Phillip Zamore at HHMI
- Professor Brenda Bass
- RNAi.net -Coverage of the world of RNA interference
- RXi Pharmaceuticals
- Scott McConchie, Attorney for Alnylam
- Sirna Therapeutics - Merck
- Steve W. Berman - Lead attorney for Utah
- Thomas Maffei, Lead Attorney for Alnylam
- Thomas Tuschl & Lab
- Wolfgang Weiss, IP Attorney for Max-Planck
Hagens Berman Sobol Shapiro LLP Takes Over the Plaintiff’s Case from Pepper Hamilton LLP
This change was made on October 31, 2011 (for seemingly obvious reasons).
Lead attorney from Hagens Berman is Debra G. Josephson. Steve W. Berman is also lised in the case according to court documents. Also, Nicholas S. Boebel at Hagens Berman is on the case according to the law firm website. Links to the web pages for these attorneys have been placed in the Left SideBar along with Links for the attorneys for the Defendants.
Leave a Reply
Recent Posts
- Cloning of Human Embryonic Stem Cells…and Human Beings - a Future Platform for Therapeutic RNAi?
- The Rise of Therapeutic Antibodies – Will RNAi Therapeutics Take As Long?
- Motion Granted - Production of the Whitehead Litigation Materials is Stayed
- Alnylam/Tekmira Lawsuits ALL Settled - Now On With Alnylam/UUtah
- Dirk Interprets Alnylam’s SEC Statement
- The Tone of the Infringment Lawsuit Filed by Alnylam and Isis Against Tekmira
- Alnylam’s Venture into Biopesticides is Not Surprising
- How the UUtah Case and the Max-Planck/ Alnylam Case v. Whitehead etal are Connected
- Brian Maffly Reports on the Battle for the Rights to siRNA in the Salt Lake Tribune
- Brief Update on the UUtah Case Against the Four Universities and Alnylam
- Perhaps Acrimony Between Tekmira and Protiva Led to Firing of the Team that Became AlCana
- Dirk and Sherk Elaborate on the Tekmira v. Alnylam Case
- Status of Tekmira Pharmaceuticals’ Lawsuit against Defendants Alnylam Pharmaceuticals and Partner Alcana Technologies
- Benitec BioPharma Likes Alnylam’s Result - A Boost for RNAi Pharmaceuticals
- Alnylam’s Stock Jumps
Archives
- May 2013 (1)
- April 2013 (1)
- January 2013 (1)
- November 2012 (2)
- October 2012 (1)
- August 2012 (4)
- July 2012 (7)
- June 2012 (14)
- May 2012 (2)
- March 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (1)
- November 2011 (2)
- October 2011 (1)
- September 2011 (10)
- July 2011 (6)
- June 2011 (4)
- May 2011 (8)
- April 2011 (7)
- March 2011 (19)
- February 2011 (18)
- January 2011 (5)
- December 2010 (1)
- November 2010 (11)
- October 2010 (31)
- September 2010 (20)
- August 2010 (13)
- July 2010 (8)
- June 2010 (26)
- May 2010 (24)
- April 2010 (10)
- March 2010 (1)
Recent Comments
- johnleavitt on The Tone of the Infringment Lawsuit Filed by Alnylam and Isis Against Tekmira
- Steve Helton on The Tone of the Infringment Lawsuit Filed by Alnylam and Isis Against Tekmira
- Dirk Haussecker on Alnylam’s Venture into Biopesticides is Not Surprising
- andrew on Alnylam’s Venture into Biopesticides is Not Surprising
- johnleavitt on Perhaps Acrimony Between Tekmira and Protiva Led to Firing of the Team that Became AlCana
- Dirk on Status of Tekmira Pharmaceuticals’ Lawsuit against Defendants Alnylam Pharmaceuticals and Partner Alcana Technologies
- sherk on Status of Tekmira Pharmaceuticals’ Lawsuit against Defendants Alnylam Pharmaceuticals and Partner Alcana Technologies
- sherk on Status of Tekmira Pharmaceuticals’ Lawsuit against Defendants Alnylam Pharmaceuticals and Partner Alcana Technologies
- tufulipo on What the Defendants Admit in Response to UUtah’s 89 Allegations in Their 2nd Amended Complaint
- johnleavitt on Alnylam with MIT and Harvard Develop a New siRNA Delivery Method
- sherk on Alnylam with MIT and Harvard Develop a New siRNA Delivery Method
- johnleavitt on A Conversation Between Judge Saris and the Attorneys – Status Conference
- Steve_382 on A Conversation Between Judge Saris and the Attorneys – Status Conference
- john on A Tekmira v. Alnylam Discovery Hearing is Scheduled for November 16 at 2 PM
- sherk on A Tekmira v. Alnylam Discovery Hearing is Scheduled for November 16 at 2 PM
What is siRNA?
Elbashir etal. (left sidebar): "Double-stranded RNA (dsRNA) induces sequence-specific posttranscriptional gene silencing in many
organisms by a process known as RNA interference (RNAi) ... 21- and 22-nt RNA fragments are the sequence-specific mediators of RNAi. The short
interfering RNAs (siRNAs) are generated by an RNase III–like processing reaction from long dsRNA.
Chemically synthesized siRNA duplexes with overhanging 3' ends mediate efficient target RNA cleavage ..." and "... (these) 21-nucleotide siRNA duplexes specifically suppress expression of endogenous and heterologous genes in different mammalian cell(s)..."
- Cenix, Debiopharm Launch Biomarker Collaboration - Genetic Engineering News
- Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive ... - Sacramento Bee
- IDT Help Identify miRNA Regulated Networks in Cystic Fibrosis - SelectScience.net (press release)
- miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier - Fort Mills Times
- Research offers promising new approach to treatment of lung cancer - HealthCanal.com
- New Lung Cancer Treatment Kills Drug-Resistant Tumors - iTech Post
- Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference ... - PR Newswire (press release)
- Caltech biologists show that microRNA-146a protects stem cells during ... - News-Medical.net
- Alnylam records RNAi delivery success to treat rare disease - FierceDrugDelivery
- Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess ... - EON: Enhanced Online News (press release)
Next Court Date
Don't know ... but I'll be there! I will be wearing a long gray beard, sunglasses, and a black Amish hat.

